food and beverage manufacturerReviewed profile

PT Genero Pharmaceuticals

Product manufacturer

Public category
Product manufacturer
Declared capabilities
5
Headquarters
Indonesia
Is this your company?Claim PT Genero Pharmaceuticals to get found by buyers, add products and certifications, correct your details, and be eligible when Talio’s AI recommends suppliers.Let our AI make the introductionGet a warm, researched intro to PT Genero Pharmaceuticals — no cold outreach.
Report a changeLog in for full recordLast reviewed 31 Jul 2026

Overview

What PT Genero Pharmaceuticals covers.

Genero is a reputable company, part of the Arya Noble Group, established in 2000. It has evolved from a dermatology product specialist for the ERHA group into an innovative company providing integrated services for the dermatology industry, including formulation, contract manufacturing, clinical research, and quality control. They are a strategic partner in supply chain management for several leading national and multinational companies.

  • Declared capabilities: custom formulation, R&D services, contract manufacturing and clinical study / CRO services.
  • Headquartered in Indonesia.

Capabilities & ingredients

Capabilities

custom formulationR&D servicescontract manufacturingclinical study / CRO servicesquality control testing

FAQ

Questions this page answers.

What does PT Genero Pharmaceuticals do?

PT Genero Pharmaceuticals is a food and beverage manufacturer based in Indonesia with declared capabilities in custom formulation, R&D services and contract manufacturing, tracked in Talio's food and beverage intelligence platform.

Is this the full Talio record?

No. This page is a public preview; proprietary metrics and workflow features remain inside authenticated Talio.

Own this company?

Get found by buyers — and the AI that recommends suppliers.

Claim this profile to appear in buyer searches, add your products and certifications, correct outdated details, and stay eligible when Talio's AI recommends suppliers.

Claiming grants reviewed submission rights only — not direct editing, suppression, or ownership of Talio-derived intelligence. Verification required.

Proprietary metrics remain in authenticated Talio.